Jan Schnitzer, MD

Institute Director
PRISM, United States

Disclosure information not submitted.

Presentation(s):

• 282 - Alpha Particle Therapy with Bi-213-DTPA-hAnnA1 Antibody Targeting Murine Ovarian Cancer Cells

  Tuesday, April 14, 2026
  4:03 PM - 4:12 PM ET